SU

Sandeep Udaypratap Singh

Active Director Designated Partner DIN 10016184
DIN 10016184 First appointment Aug 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Aug 2022
Shareholding value - Across - companies

About Sandeep Udaypratap Singh

Sandeep Udaypratap Singh has 3 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Nucleus Speciality Pharma Llp. Engaged in General Business. Contributes to corporate operations.

DIN 10016184
Primary Designation Designated Partner
First Appointment 19 Aug 2022
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Designated Partner 19 Aug 2022 2022 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Nucleus Speciality Pharma Llp

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Sandeep Udaypratap Singh

Sandeep Udaypratap Singh has 3 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Nucleus Speciality Pharma Llp. Engaged in General Business. Contributes to corporate operations.

Sandeep Udaypratap Singh is associated with 1 company as Designated Partner.

Sandeep Udaypratap Singh has expertise in General Business.

Sandeep Udaypratap Singh has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available